{"entity":{"type":"insider","cik":"0001843113","url":"/insider/0001843113","json_url":"/insider/0001843113.json","name":"ABALLI JOHN","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":7,"first":"2022-12-09","last":"2026-03-04","span_basis":"filed_date"},"name_variants":[{"name":"ABALLI JOHN","source":"filing","n_filings":7,"first_seen":"2022-12-09","last_seen":"2026-03-04"}],"transactions":[{"id":6032019,"accession":"0001843113-26-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001843113-26-000004","line_url":"/filing/0001843113-26-000004#line-2","is_derivative":false,"issuer_cik":"0001274737","issuer_name":"EXAGEN INC.","issuer_ticker":"XGN","issuer_name_source":null,"issuer_url":"/issuer/0001274737","owner_cik":"0001843113","owner_name":"ABALLI JOHN","owner_display_name":"ABALLI JOHN","owner_url":"/insider/0001843113","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15698.0,"shares_display":"15,698","price_per_share":3.62,"price_display":"3.62","price_state":"stated","total_value":56826.76,"total_display":"56,826.76","total_whole":"56,827","shares_owned_after":687299.0,"shares_owned_after_display":"687,299","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-03","filed_date":"2026-03-04","scope":"insider"},{"id":6065518,"accession":"0001843113-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001843113-26-000002","line_url":"/filing/0001843113-26-000002#line-1","is_derivative":false,"issuer_cik":"0001274737","issuer_name":"EXAGEN INC.","issuer_ticker":"XGN","issuer_name_source":null,"issuer_url":"/issuer/0001274737","owner_cik":"0001843113","owner_name":"ABALLI JOHN","owner_display_name":"ABALLI JOHN","owner_url":"/insider/0001843113","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11430.0,"shares_display":"11,430","price_per_share":3.61,"price_display":"3.61","price_state":"stated","total_value":41262.3,"total_display":"41,262.30","total_whole":"41,262","shares_owned_after":702997.0,"shares_owned_after_display":"702,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-24","filed_date":"2026-02-25","scope":"insider"},{"id":4253625,"accession":"0001843113-25-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001843113-25-000003","line_url":"/filing/0001843113-25-000003#line-1","is_derivative":false,"issuer_cik":"0001274737","issuer_name":"EXAGEN INC.","issuer_ticker":"XGN","issuer_name_source":null,"issuer_url":"/issuer/0001274737","owner_cik":"0001843113","owner_name":"ABALLI JOHN","owner_display_name":"ABALLI JOHN","owner_url":"/insider/0001843113","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31787.0,"shares_display":"31,787","price_per_share":11.8161,"price_display":"11.82","price_state":"stated","total_value":375598.3707,"total_display":"375,598.37","total_whole":"375,598","shares_owned_after":714427.0,"shares_owned_after_display":"714,427","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-16","filed_date":"2025-10-20","scope":"insider"},{"id":2250155,"accession":"0001274737-24-000094","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001274737-24-000094","line_url":"/filing/0001274737-24-000094#line-1","is_derivative":false,"issuer_cik":"0001274737","issuer_name":"EXAGEN INC.","issuer_ticker":"XGN","issuer_name_source":null,"issuer_url":"/issuer/0001274737","owner_cik":"0001843113","owner_name":"ABALLI JOHN","owner_display_name":"ABALLI JOHN","owner_url":"/insider/0001843113","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":24305.0,"shares_display":"24,305","price_per_share":2.81,"price_display":"2.81","price_state":"stated","total_value":68297.05,"total_display":"68,297.05","total_whole":"68,297","shares_owned_after":689799.0,"shares_owned_after_display":"689,799","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-14","filed_date":"2024-11-18","scope":"insider"},{"id":2520727,"accession":"0001274737-24-000052","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001274737-24-000052","line_url":"/filing/0001274737-24-000052#line-1","is_derivative":false,"issuer_cik":"0001274737","issuer_name":"EXAGEN INC.","issuer_ticker":"XGN","issuer_name_source":null,"issuer_url":"/issuer/0001274737","owner_cik":"0001843113","owner_name":"ABALLI JOHN","owner_display_name":"ABALLI JOHN","owner_url":"/insider/0001843113","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40401.0,"shares_display":"40,401","price_per_share":1.92,"price_display":"1.92","price_state":"stated","total_value":77569.92,"total_display":"77,569.92","total_whole":"77,570","shares_owned_after":40401.0,"shares_owned_after_display":"40,401","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-16","filed_date":"2024-05-16","scope":"insider"},{"id":8382010,"accession":"0001274737-23-000094","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001274737-23-000094","line_url":"/filing/0001274737-23-000094#line-1","is_derivative":false,"issuer_cik":"0001274737","issuer_name":"EXAGEN INC.","issuer_ticker":"XGN","issuer_name_source":null,"issuer_url":"/issuer/0001274737","owner_cik":"0001843113","owner_name":"ABALLI JOHN","owner_display_name":"ABALLI JOHN","owner_url":"/insider/0001843113","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33819.0,"shares_display":"33,819","price_per_share":1.7451,"price_display":"1.75","price_state":"stated","total_value":59017.5369,"total_display":"59,017.54","total_whole":"59,018","shares_owned_after":415984.0,"shares_owned_after_display":"415,984","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-17","filed_date":"2023-10-18","scope":"insider"},{"id":6640763,"accession":"0001274737-22-000083","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001274737-22-000083","line_url":"/filing/0001274737-22-000083#line-1","is_derivative":false,"issuer_cik":"0001274737","issuer_name":"EXAGEN INC.","issuer_ticker":"XGN","issuer_name_source":null,"issuer_url":"/issuer/0001274737","owner_cik":"0001843113","owner_name":"ABALLI JOHN","owner_display_name":"ABALLI JOHN","owner_url":"/insider/0001843113","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":90000.0,"shares_display":"90,000","price_per_share":2.68,"price_display":"2.68","price_state":"stated","total_value":241200.0,"total_display":"241,200.00","total_whole":"241,200","shares_owned_after":440000.0,"shares_owned_after_display":"440,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-08","filed_date":"2022-12-09","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001274737","name":"EXAGEN INC.","url":"/issuer/0001274737","role":"Director, Officer (President and CEO)","n_filings":7,"first_seen":"2022-12-09","last_seen":"2026-03-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001843113","retrieved_at":"2026-08-26T02:46:11+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}